Manufacturing Vaccines in Adherent Cell Lines Using Disposable Multi-tray Bioreactors - By allowing a single system to be used from laboratory- to commercial-scale, multi-tray bioreactors can facilita

ADVERTISEMENT

Manufacturing Vaccines in Adherent Cell Lines Using Disposable Multi-tray Bioreactors
By allowing a single system to be used from laboratory- to commercial-scale, multi-tray bioreactors can facilitate scale up and accelerate vaccine development.


BioPharm International


References:

1 Cesano A, Visonneau S, Jeglum KA, Owen J, Wilkinson K, Carner K, et al. Phase i clinical trial with a human major histocompatibility complex nonrestricted cytotoxic t-cell line (tall-104) in dogs with advanced tumors. Cancer Res. 1996; 56:3021–3029.

2. Schwander E, Ramusen, H. Manufacturing of lots of human T lymphocytes for cell therapy: A new process based on disposable bioreactors. Gen Eng News. 2005 Apr 15; 25(8).

3. Schlenke P, et al. Serum-free transient expression of antibodies using 40 tray cell factories. Poster. Laupheim, Germany: Renschler Biotechnologie Gmbh.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Pfizer to Acquire Vaccines from Baxter
July 30, 2014
GSK Submits EU Regulatory Filing for Malaria Vaccine Candidate
July 29, 2014
Bristol-Myers Squibb and Ono Pharmaceutical Collaborate on Immunotherapies
July 28, 2014
FDA Accepts First Biosimilar Filing
July 24, 2014
Compounding Pharmacy Issues Recall, But Challenges FDA Decision
July 22, 2014
Author Guidelines
Source: BioPharm International,
Click here